Crowdonomics
This isn’t Med-X, Inc.’s most recent raise. Rule 506(c) · Equity · Sep 2025 (Upcoming) is more current.View latest round
Med-X, Inc.

Reg A+ · Equity · Aug 2015

WithdrawnReg A+Equity
via the platform · last checked Sep 24, 2026
Raised
$872.5K / $15M max
6% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

No financial statements linked to this round

The issuer's filing for this offering hasn't been parsed into fiscal-year statements yet.

Amendments to this offering

8 amendments
  1. May 23, 2019
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  2. Jun 14, 2018
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  3. May 16, 2018
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  4. Jun 9, 2017
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  5. Jan 26, 2016
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  6. Dec 21, 2015
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  7. Dec 4, 2015
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  8. Oct 15, 2015
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Shares offered25,000,000

Offering details

Target—
Max$15,000,000
Min investment—
OpenedAug 27, 2015
Deadline—
ClosedJun 19, 2019
Days active1,392

Links & provenance

Source: SEC EDGAR
0001477932-15-005601
Last synced Sep 24, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.